Proteomic Studies of Psychiatric Disorders.

Abstract

Many diseases result from programming effects in utero. This chapter describes recent advances in proteomic studies which have improved our understanding of the underlying pathophysiological pathways in the major psychiatric disorders, resulting in the development of potential novel biomarker tests. Such tests should be based on measurement of blood-based proteins given the ease of accessibility of this medium and the known connections between the periphery and the central nervous system. Most importantly, emerging biomarker tests should be developed on lab-on-a-chip and other handheld devices to enable point-of-care use. This should help to identify individuals with psychiatric disorders much sooner than ever before, which will allow more rapid treatment options for the best possible patient outcomes.

• Authors: Paul C Guest
• Journal: Methods in molecular biology (Clifton, N.J.) (Methods Mol Biol) Vol. 1735 Pg. 59-89 ( 2018) ISSN: 1940-6029 [Electronic] United States
• PMID: 29380307 (Publication Type: Journal Article, Review)

Chemical References

• Biomarkers
• Proteome

Topics

• Animals
• Biomarkers
• Brain (metabolism)
• Humans
• Immunoassay (methods)
• Lab-On-A-Chip Devices
• Mass Spectrometry
• Mental Disorders (diagnosis, metabolism, psychology)
• Neurosecretory Systems (metabolism)
• Peripheral Nerves (metabolism)
• Proteome
• Proteomics (methods)